Cardiovascular and renal outcomes with sodium glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus: A system review and network meta-analysis
Lei Tian(Capital Medical University), Yaoxian Wang(First Affiliated Hospital of Henan University), Hanwen Yang(China-Japan Friendship Hospital), Huijuan Zheng(Inner Mongolia Agricultural University), Wenjing Zhao(Capital Medical University), Jingyi Tang(Beijing University of Chinese Medicine), Mengqi Zhou(Beijing University of Chinese Medicine), Weijing Liu(Beijing University of Chinese Medicine), Sinan Ai(Beijing University of Chinese Medicine)
Cited by 9
Related Papers
Collision of herbal medicine and nanotechnology: a bibliometric analysis of herbal nanoparticles from 2004 to 2023
|Journal of Nanobiotechnology|2024|72
Lactobacillus plantarum improves the efficiency of sheep manure composting and the quality of the final product
|Bioresource Technology|2019|63
Lysosomal dysfunction–induced autophagic stress in diabetic kidney disease
|Journal of Cellular and Molecular Medicine|2020|48
Canagliflozin for Prevention of Cardiovascular and Renal Outcomes in type2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
|Frontiers in Pharmacology|2021|32
Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease
|Frontiers in Medicine|2021|31